StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Ascendis Pharma A/S
NasdaqGS:ASND
Sector
Location
Market Cap
USD 10.68 B
Share Price
USD 176.49
Avg Daily Volume
488,423
Change (1 day)
0.44%
Change (1 year)
28.51%
Change (YTD)
28.20%
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2024: USD -328.29 M
Ascendis Pharma A/S Operating Cash Flow is USD -328.29 M for the Trailing 12 Months (TTM) ending December 31, 2024, a -35.02% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2023 was USD -505.24 M, a -3.51% change year over year.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2022 was USD -523.60 M, a 7.83% change year over year.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2021 was USD -485.57 M, a 53.98% change year over year.
-
Ascendis Pharma A/S Operating Cash Flow for the Trailing 12 Months (TTM) ending December 31, 2020 was USD -315.36 M, a 61.27% change year over year.
Competitors
GE HealthCare Technologies Inc.
USD 76.50
GEHC
+0.99
1.31%
Laboratory Corporation of America Holdings
USD 253.63
LH
-5.44
-2.10%
Torrent Pharmaceuticals Limited
USD 39.07
TORNTPHARM.NS
+0.13
0.33%
Regencell Bioscience Holdings Limited
USD 16.57
RGC
-0.83
-4.80%
Laurus Labs Limited
USD 9.28
LAURUSLABS.NS
+0.02
0.27%
ADMA Biologics, Inc.
USD 18.47
ADMA
+0.13
0.71%
Ipca Laboratories Limited
USD 17.00
IPCALAB.NS
+0.16
0.93%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.08
002603.SZ
+0.02
0.94%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
+0.04
1.12%
Pfizer Limited
USD 64.72
PFIZER.NS
+0.89
1.39%
BGI Genomics Co., Ltd.
USD 6.86
300676.SZ
-0.02
-0.31%
Eris Lifesciences Limited
USD 20.39
ERIS.NS
+0.06
0.28%
Liaoning Cheng Da Co., Ltd.
USD 1.60
600739.SS
+0.03
2.15%
Vimian Group AB (publ)
USD 4.50
VIMIAN.ST
+0.08
1.75%
Hybio Pharmaceutical Co., Ltd.
USD 2.54
300199.SZ
-0.07
-2.58%
NovoCure Limited
USD 18.46
NVCR
+0.27
1.48%
Harmony Biosciences Holdings, Inc.
USD 34.33
HRMY
+0.04
0.12%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.14
002020.SZ
+0.03
1.38%
Adaptive Biotechnologies Corporation
USD 12.08
ADPT
+0.15
1.26%
Arcutis Biotherapeutics, Inc.
USD 15.27
ARQT
+1.05
7.38%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
GE HealthCare Technologies Inc.
USD 76.50
GEHC
+0.99
1.31%
Laboratory Corporation of America Holdings
USD 253.63
LH
-5.44
-2.10%
Torrent Pharmaceuticals Limited
USD 39.07
TORNTPHARM.NS
+0.13
0.33%
Regencell Bioscience Holdings Limited
USD 16.57
RGC
-0.83
-4.80%
Laurus Labs Limited
USD 9.28
LAURUSLABS.NS
+0.02
0.27%
ADMA Biologics, Inc.
USD 18.47
ADMA
+0.13
0.71%
Ipca Laboratories Limited
USD 17.00
IPCALAB.NS
+0.16
0.93%
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
USD 2.08
002603.SZ
+0.02
0.94%
Hubei Jumpcan Pharmaceutical Co., Ltd.
USD 3.66
600566.SS
+0.04
1.12%
Pfizer Limited
USD 64.72
PFIZER.NS
+0.89
1.39%
BGI Genomics Co., Ltd.
USD 6.86
300676.SZ
-0.02
-0.31%
Eris Lifesciences Limited
USD 20.39
ERIS.NS
+0.06
0.28%
Liaoning Cheng Da Co., Ltd.
USD 1.60
600739.SS
+0.03
2.15%
Vimian Group AB (publ)
USD 4.50
VIMIAN.ST
+0.08
1.75%
Hybio Pharmaceutical Co., Ltd.
USD 2.54
300199.SZ
-0.07
-2.58%
NovoCure Limited
USD 18.46
NVCR
+0.27
1.48%
Harmony Biosciences Holdings, Inc.
USD 34.33
HRMY
+0.04
0.12%
Zhejiang Jingxin Pharmaceutical Co., Ltd.
USD 2.14
002020.SZ
+0.03
1.38%
Adaptive Biotechnologies Corporation
USD 12.08
ADPT
+0.15
1.26%
Arcutis Biotherapeutics, Inc.
USD 15.27
ARQT
+1.05
7.38%